News › Clinical Practice, Industry News, Patient Care

FDA Approves Juvéderm Voluma XC for Enhancement of the Chin Region

June 15, 2020

Allergan Aesthetics, an AbbVie company, announced the FDA approval of Juvéderm Voluma XC for the augmentation of the chin region to improve the chin profile in adults over the age of 21.1 The Juvéderm collection of fillers has a broad portfolio of specifically tailored treatment options, and this latest approval marks its fifth approved indication in the U.S.
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Merz Aesthetics’ Radiesse Receives FDA Approval for Décolleté Wrinkles
    • New Book “Get Found, Get Booked” Reveals a Smarter, Ethical Approach to Marketing for Med Spas and Wellness Practices
    • Growth, Capital and Control: Navigating Private Equity in Aesthetics
    • Med Spas Under the Microscope – The View From The FDA
    • Revance and Teoxane Announce RHA Dynamic Volume is Now Available